Immuneering Corporation
IMRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61,037 | -$53,472 | -$50,514 | -$33,536 |
| Dep. & Amort. | $385 | $352 | $797 | $159 |
| Deferred Tax | $0 | $0 | $0 | -$307 |
| Stock-Based Comp. | $6,501 | $5,727 | $0 | $1,803 |
| Change in WC | -$925 | -$975 | $1,717 | $900 |
| Other Non-Cash | $76 | -$602 | $3,898 | $130 |
| Operating Cash Flow | -$55,000 | -$48,969 | -$44,101 | -$30,851 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$85 | -$343 | -$742 | -$61 |
| Net Acquisitions | $0 | $0 | $0 | $70 |
| Inv. Purchases | -$5,410 | -$44,661 | -$50,105 | -$75,626 |
| Inv. Sales/Matur. | $31,930 | $52,300 | $92,678 | $75,616 |
| Other Inv. Act. | $0 | $0 | $0 | -$75,616 |
| Investing Cash Flow | $26,435 | $7,296 | $41,831 | -$75,616 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,237 | $28,200 | $19 | $120,319 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,066 | $241 | $0 | $23,946 |
| Financing Cash Flow | $5,304 | $28,441 | $19 | $144,265 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$23,261 | -$13,231 | -$2,251 | $37,798 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,406 | $72,637 | $74,888 | $37,090 |
| End Cash | $36,145 | $59,406 | $72,637 | $74,888 |
| Free Cash Flow | -$55,084 | -$49,311 | -$44,844 | -$30,912 |